Compression Therapy Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Compression Therapy Market: By Technology (Static Compression Therapy, Dynamic Compression Therapy), By Product (Compression Garments, Compression Pumps, Compression Braces), By Application (Venous Leg Ulcers, Deep Vein Thrombosis Treatment, Lymphedema Treatment, Other Applications) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

The compression therapy market is valued at USD 2,539.2 Million in 2021, and it is projected to grow at a significant CAGR of 12.3% over 2022-2028. Compression therapy, which involves applying external pressure to the human body, is the most well-known and crucial supplementary treatment for venous and lymphatic illnesses. The rising launch of compression therapy devices is also expected to drive the growth of this market. Doctors have prescribed compression therapy for thousands of years, as far back as the Hippocrates of ancient Greece. The increased acceptance of preventative care and/or rehabilitation as a long-term approach to handling various venous disorders is driving the global market for compression therapy. Poor blood flow, often known as chronic venous insufficiency (CVI), is a frequent ailment treated with compression therapy. According to Trusted Source research from 2014, CVI affects 25 to 40% of women and 10 to 20% of males. Because older adults are more sensitive to numerous health issues, the growing global geriatric population is considered a significant factor promoting market expansion. These variables drive patient demand for and use various treatment modalities, such as compression therapy. Compression therapy products are becoming more popular as a first-line treatment for significant target indications and post-surgery rehabilitation. Today, different grades of compression stockings are available, ranging from over-the-counter support hoses to prescription devices. Emerging economies such as China, India, Brazil, and Mexico are expected to provide many potential possibilities for compression therapy market competitors during the projected period. In 2021, the compression garments segment had the most market share. This can majorly be attributed to the use of compression garments in a wide range of indications, such as varicose veins, edema, Deep vein thrombosis (DVT), lymphedema, and management of several chronic conditions.

Recent Market Developments:

In January 2022, Convatec Group Plc a global medical solutions company focused on the management of chronic conditions, is pleased to announce that it has entered into a definitive agreement to acquire Triad Life Sciences Inc(1) (‘Triad’), a US-focused medical device company that develops biologically-derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns.

In July 2021, Essity’s acquisition of ABIGO Medical is completed. The process following the acquisition of the remaining 25% of the shares of ABIGO Medical AB is completed and the company is now a wholly owned subsidiary of Essity. As per the terms of the transaction, ABIGO Medicals pharma business has been divested and sold to the company’s founder Jan G. Smith.

Compression Therapy Market

MARKET SUMMARY
-
12.3%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 12.3%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Compression Therapy Market

  • The global compression therapy market report gives comprehensive outlook on beverage dispenser equipment across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The compression therapy market report gives historical, current, and future market sizes (US$ Mn) on the basis of technology, product, application, and geography.
Key Players
  • Medtronic PLC
  • Paul Hartmann AG
  • SIGVARIS, Inc
  • Smith & Nephew PL
  • Tactile Medical
Compression Therapy Market Dynamics

Increased chronic venous insufficiency and deep vein thrombosis cases are driving the growth of the global compression therapy market. Chronic venous insufficiency is the most cited condition for compression therapy. Obesity, pregnancy, blood clots, varicose veins, and other injuries are risk factors for this illness. The use of other means of therapy and ignorance and lack of information about compression therapies are some of the primary barriers to this industry, particularly in many low and middle-income nations


North-America Got Significant Share

Compression Therapy Market

In 2021, North America is expected to be the most important regional market for compression therapy goods. This dominance can be attributed to reasons like substantial investment in research and development, new product introductions, and the high frequency of venous illnesses in nations like the United States. Additionally, the increased prevalence of numerous target diseases, as well as the presence of several compression therapy product manufacturers, are driving regional market expansion. The Asia-Pacific area is projected to develop at the fastest rate during the study period, owing to rising per capita healthcare spending in emerging economies, an increasing number of patients with venous insufficiencies, and increased awareness of numerous target conditions in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The compression therapy market  report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Compression Therapy Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The compression therapy market is projected to expand at a CAGR of 12.3% during the forecast period.

3M Company, ArjoHuntleigh, Inc, Bio Compression Systems, Inc, ConvaTec, Inc, DJO Global, Inc

North America is the fastest-growing region for compression therapy market


Report

Table Of Content


Report

Company Profile

  • 3M Company
  • ArjoHuntleigh, Inc
  • Bio Compression Systems, Inc
  • ConvaTec, Inc
  • DJO Global, Inc
  • Medi GmbH & Co. KG
  • Medtronic PLC
  • Paul Hartmann AG
  • SIGVARIS, Inc
  • Smith & Nephew PL
  • Tactile Medical

Description

The compression therapy market is valued at USD 2,539.2 Million in 2021, and it is projected to grow at a significant CAGR of 12.3% over 2022-2028. Compression therapy, which involves applying external pressure to the human body, is the most well-known and crucial supplementary treatment for venous and lymphatic illnesses. The rising launch of compression therapy devices is also expected to drive the growth of this market. Doctors have prescribed compression therapy for thousands of years, as far back as the Hippocrates of ancient Greece. The increased acceptance of preventative care and/or rehabilitation as a long-term approach to handling various venous disorders is driving the global market for compression therapy. Poor blood flow, often known as chronic venous insufficiency (CVI), is a frequent ailment treated with compression therapy. According to Trusted Source research from 2014, CVI affects 25 to 40% of women and 10 to 20% of males. Because older adults are more sensitive to numerous health issues, the growing global geriatric population is considered a significant factor promoting market expansion. These variables drive patient demand for and use various treatment modalities, such as compression therapy. Compression therapy products are becoming more popular as a first-line treatment for significant target indications and post-surgery rehabilitation. Today, different grades of compression stockings are available, ranging from over-the-counter support hoses to prescription devices. Emerging economies such as China, India, Brazil, and Mexico are expected to provide many potential possibilities for compression therapy market competitors during the projected period. In 2021, the compression garments segment had the most market share. This can majorly be attributed to the use of compression garments in a wide range of indications, such as varicose veins, edema, Deep vein thrombosis (DVT), lymphedema, and management of several chronic conditions.

Recent Market Developments:

In January 2022, Convatec Group Plc a global medical solutions company focused on the management of chronic conditions, is pleased to announce that it has entered into a definitive agreement to acquire Triad Life Sciences Inc(1) (‘Triad’), a US-focused medical device company that develops biologically-derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns.

In July 2021, Essity’s acquisition of ABIGO Medical is completed. The process following the acquisition of the remaining 25% of the shares of ABIGO Medical AB is completed and the company is now a wholly owned subsidiary of Essity. As per the terms of the transaction, ABIGO Medicals pharma business has been divested and sold to the company’s founder Jan G. Smith.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX